Search Results
Dr. Fong Discusses Memory T Cell Responses Following Anti-CTLA-4 Antibody Treatment
Can the Immune System See Cancer?, with Lawrence Fong
Dr. Fong on Inducing an Immune Response With a Patient’s Tumor
Activating Your Immune System Against Prostate Cancer, with Lawrence Fong
Anti-PD-1 or anti-CTLA-4 in first line therapy?
Dr. Fong Discusses a Phase II Trial of Intramoral Electroporation of Plasmid IL-12 in Melanoma
Webinar - Dr. Larry Fong on Immuno-Oncology
Kidney Cancer Immunotherapy: CTLA-4 & Vaccine Clinical Trials
Cancer Immunotherapy - A Talk with Dr Lawrence Fong, Leader of Cancer Immunotherapy Program at UCSF
JK08, a fusion protein of IL-15 and anti-CTLA-4 antibody, in solid tumors
Dr. Tap on the Potential to Combine KIT and CTLA-4 Blockade in Patients With GIST
Dr. Tap on Combined KIT and CTLA-4 Blockade in Patients with GIST
